Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Neurofibromatosis 1 1Neurofibroma 1

Interventions

Magnetic Resonance Spectroscopy 77Temozolomide 71Specimen Handling 49Radiotherapy 47Radiosurgery 35Cyclophosphamide 28Bevacizumab 25pembrolizumab 23Radiation 23Biopsy 23Nivolumab 21Carboplatin 15fludarabine 14X-Rays 13Ipilimumab 13Surgical Procedures, Operative 12Lomustine 12Topotecan 11Irinotecan 11Blood Specimen Collection 11Vincristine 10Cisplatin 10trametinib 9dinutuximab 9abemaciclib 9AZD 6244 9lutetium Lu 177 dotatate 8Surveys and Questionnaires 8Proton Therapy 8Immunoglobulin G 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Deoxycholic Acid × CNS × 90 days × Clear all
NCT06300502 2026-04-22

Assessing the Efficacy of Repeat, Monthly Treatments of Deoxycholate for NF1 Associated Cutaneous Neurofibromas (cNFs)

Massachusetts General Hospital

Phase 1 Enrolling by invitation
15 enrolled
CNS

Neurofibroma, Neurofibromatosis 1

Data powered by HemOnc (CC BY 4.0) Colophon âš¡